Surgery Partners, Inc. (NASDAQ:SGRY) Receives $39.63 Consensus Target Price from Brokerages

Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) has been given an average rating of "Moderate Buy" by the nine analysts that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $39.63.

A number of analysts have commented on SGRY shares. UBS Group began coverage on shares of Surgery Partners in a research note on Monday, October 14th. They set a "buy" rating and a $38.00 price target for the company. Citigroup dropped their price objective on Surgery Partners from $38.00 to $36.00 and set a "buy" rating on the stock in a research note on Wednesday, August 7th. KeyCorp started coverage on shares of Surgery Partners in a report on Friday, October 11th. They set a "sector weight" rating on the stock. Cantor Fitzgerald reiterated an "overweight" rating and issued a $43.00 price target on shares of Surgery Partners in a research report on Friday, October 4th. Finally, Macquarie initiated coverage on shares of Surgery Partners in a research note on Friday, June 28th. They issued an "outperform" rating and a $31.00 target price on the stock.

Hedge Funds Weigh In On Surgery Partners

Hedge funds and other institutional investors have recently modified their holdings of the stock. Janus Henderson Group PLC raised its holdings in Surgery Partners by 7,987.1% in the first quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company's stock worth $74,701,000 after purchasing an additional 2,473,282 shares in the last quarter. Deerfield Management Company L.P. Series C increased its position in Surgery Partners by 47.7% during the 2nd quarter. Deerfield Management Company L.P. Series C now owns 4,707,287 shares of the company's stock valued at $111,986,000 after buying an additional 1,520,484 shares in the last quarter. Point72 Asset Management L.P. purchased a new position in Surgery Partners during the second quarter valued at $29,288,000. Vanguard Group Inc. raised its stake in Surgery Partners by 10.4% during the fourth quarter. Vanguard Group Inc. now owns 7,417,609 shares of the company's stock valued at $237,289,000 after buying an additional 698,845 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in Surgery Partners by 26.7% in the second quarter. Dimensional Fund Advisors LP now owns 2,801,091 shares of the company's stock worth $66,643,000 after acquiring an additional 589,499 shares in the last quarter.

Surgery Partners Price Performance

Shares of NASDAQ SGRY traded down $1.40 during midday trading on Friday, reaching $29.47. The company's stock had a trading volume of 753,361 shares, compared to its average volume of 939,796. The company has a market cap of $3.75 billion, a P/E ratio of -109.14, a P/E/G ratio of 2.45 and a beta of 2.75. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.69 and a current ratio of 1.83. The business's 50 day moving average price is $31.27 and its two-hundred day moving average price is $28.06. Surgery Partners has a fifty-two week low of $22.05 and a fifty-two week high of $36.92.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported $0.21 earnings per share for the quarter, topping analysts' consensus estimates of $0.20 by $0.01. Surgery Partners had a negative net margin of 1.17% and a positive return on equity of 2.96%. The firm had revenue of $762.10 million for the quarter, compared to analysts' expectations of $735.94 million. During the same quarter in the previous year, the firm posted $0.25 earnings per share. The company's revenue was up 14.2% on a year-over-year basis. On average, analysts forecast that Surgery Partners will post 0.84 EPS for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.